Literature DB >> 33565131

Depression and Nigral Neuron Density in Lewy Body Spectrum Diseases.

Laura Saari1,2, Lauri Heiskanen1,2, Maria Gardberg3, Valtteri Kaasinen1,2.   

Abstract

Parkinson's disease and other Lewy body spectrum diseases (LBDs) are associated with a specific risk for clinical depression. In the present clinicopathological study with 73 patients with LBD, we observed that the substantia nigra pars compacta dopamine neuron density was markedly lower in patients who had comorbid depression antemortem than in nondepressed patients (1.52 vs 2.32 n/mm2 , p = 0.004). There were no differences in cognition, motor disease severity, antiparkinsonian medications, or disease duration between groups. The results implicate the substantia nigra as an important psychomotor modulatory area of mood in patients with Lewy body disorders. ANN NEUROL 2021;;89:1046-1050.
© 2021 The Authors. Annals of Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.

Entities:  

Mesh:

Year:  2021        PMID: 33565131     DOI: 10.1002/ana.26046

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  5 in total

1.  Height and nigral neuron density in Parkinson's disease.

Authors:  Laura Saari; Emmilotta A Backman; Pia Wahlsten; Maria Gardberg; Valtteri Kaasinen
Journal:  BMC Neurol       Date:  2022-07-11       Impact factor: 2.903

Review 2.  The neuropsychiatry of Parkinson's disease: advances and challenges.

Authors:  Daniel Weintraub; Dag Aarsland; Kallol Ray Chaudhuri; Roseanne D Dobkin; Albert Fg Leentjens; Mayela Rodriguez-Violante; Anette Schrag
Journal:  Lancet Neurol       Date:  2022-01       Impact factor: 44.182

3.  Delirium-Onset of Prodromal Dementia With Lewy Bodies-Putative Brainstem-Related Pathomechanism and Clinical Relevance.

Authors:  Niels Hansen; Charles Timäus; Caroline Bouter; Claudia Lange; Katharina Packroß
Journal:  Front Aging Neurosci       Date:  2022-02-25       Impact factor: 5.750

4.  Depressive symptoms before and after Parkinson's diagnosis-A longitudinal analysis.

Authors:  Shengfang Song; Zhehui Luo; Chenxi Li; Xuemei Huang; Eric J Shiroma; Eleanor M Simonsick; Honglei Chen
Journal:  PLoS One       Date:  2022-07-29       Impact factor: 3.752

5.  Neuropathological studies of serotonergic and noradrenergic systems in Lewy body disease patients with delusion or depression.

Authors:  Masashi Mizutani; Terunori Sano; Masayuki Ohira; Masaki Takao
Journal:  Psychiatry Clin Neurosci       Date:  2022-06-28       Impact factor: 12.145

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.